« Return to News | Awards & Advancement | CROs/Service Providers

ClinTec International launches US headquarters

Friday, July 9, 2010 07:29 AM

Glasgow, U.K.-based global clinical research organization ClinTec International has unveiled a significant expansion into the U.S., with the launch of its New York office and the appointment of Susan Pavone as Associate Director of U.S. Business Operations.

ClinTec has expanded into over 40 countries worldwide - with its U.S. operations centered on servicing major international companies on global projects by partnering with U.S. CROs that had limited or no international presence. The company said the launch of American headquarters and Pavone’s appointment will enable it to offer prospective U.S. clients the chance to access global clinical research capabilities through a single partner.

ClinTec President and CEO Dr. Rabinder Buttar said, “We have established a strong presence in the international marketplace by placing expert clinical research staff in all key emerging and established markets. Susan Pavone has extensive knowledge of international clinical research and the new U.S. facilities will prove an invaluable asset to American companies looking to tap into our globalized resources and expertise.” Pavone spent eight years managing the business operations of Pfizer’s internal CRO.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.